- Evonik and Higuchi opened an Open Pharma Lab in Yokohama providing local access to EUDRAGIT polymers.
- The lab opened May 1 to deliver hands-on formulation support, customer-specific technical services and access to Evonik’s global drug-delivery expertise.
- Evonik recently invested in an India Research Hub in Mumbai and an aqueous dispersion drying facility for EUDRAGIT polymers in Darmstadt to boost supply security.
- The partnership began when Higuchi introduced German methacrylate technologies to Japan and expanded in the 1960s with film-coating excipients.
Open Pharma Lab in Yokohama
Evonik and Higuchi opened a joint Open Pharma Lab in Yokohama, operational from May 1, providing local formulators hands-on access to EUDRAGIT polymers and related system solutions for oral dosage form development.
Capabilities and services
The facility offers collaborative formulation support, customer-specific technical services and access to Evonik's global drug-delivery expertise to accelerate formulation development and shorten timelines for patient-centric solid oral products.
EUDRAGIT polymers
EUDRAGIT polymers are established excipient technologies used to control release profiles and support the design of stable solid dosage forms; Evonik combines these materials with formulation science and application know-how.
Partnership and regional strategy
The partnership traces back decades after Higuchi introduced German methacrylate technologies to Japan and expanded in the 1960s with film-coating excipients; the collaboration continues via initiatives such as the EUDRAGIT Seminar series. The lab complements Evonik investments including an India Research Hub in Mumbai and an aqueous dispersion drying facility for EUDRAGIT polymers in Darmstadt to bolster supply security.
